Inhibrx Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	391	223	-	-
Enterprise Value	319	28	-	-
Last Close Price	27.52	15.40	-	-
PE Ratio	-	0.13	-	-
PS Ratio	284.54	1114.65	-	-
PB Ratio	5.81	1.67	-	-
P/TBV Ratio	5.81	1.67	-	-
EV/Sales Ratio	227.55	142.16	-	-
Debt / Equity Ratio	1.56	0.06	4.83	-0.69
Asset Turnover	0.01	0.00	0.01	-
Inventory Turnover	46.73	34.28	35.84	-
Quick Ratio	4.82	3.76	4.95	0.01
Current Ratio	4.98	3.94	5.25	0.30
Return on Equity (ROE)	-113.71%	1905.92%	-1333.38%	-
Return on Assets (ROA)	-26.29%	-67.38%	-84.42%	-
Return on Capital (ROIC)	-31.17%	-83.29%	-108.99%	-
Earnings Yield	-41.09%	757.00%	-	-
FCF Yield	-35.18%	-88.37%	-	-
Buyback Yield / Dilution	-13.93%	-27.17%	-	-

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q